Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain

被引:111
|
作者
Li, XY [1 ]
Green, MR [1 ]
机构
[1] UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,HOWARD HUGHES MED INST,WORCESTER,MA 01605
关键词
ATF-2; transcription activator; bZIP DNA-binding domain; activation domain; cell-type specificity;
D O I
10.1101/gad.10.5.517
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ATF-2 is a cellular basic region-leucine zipper (bZIP) transcription factor that can mediate diverse transcriptional responses, including activation by the adenovirus E1a protein. ATF-2 contains an activation domain, required for transcriptional activity, but in the absence of an appropriate inducer, full-length ATF-2 is transcriptionally inactive. Here we have investigated the mechanism underlying this regulated inhibition of ATF-2 transcriptional activity. We show that the region of ATF-2 that suppresses the activation region is the bZIP DNA-binding domain and that maximal inhibition requires both the basic region and leucine zipper subdomains. Inhibition is activation domain specific: The ATF-2 bZIP suppresses the ATF-2 and the related E1a activation domains but not acidic- and glutamine-rich activation domains. In vitro protein interaction assays demonstrate that the ATF-2 activation domain and bZIP specifically bind to one another. Finally, we show that bZIP-mediated inhibition can be modulated in a cell-type-specific manner by another sequence element within ATF-2. On the basis of these and other data, we propose that the ATF-2 bZIP and activation domain are engaged in an inhibitory intramolecular interaction and that inducers of ATF-2 disrupt this interaction to activate transcription.
引用
收藏
页码:517 / 527
页数:11
相关论文
共 50 条
  • [31] THE DNA-BINDING DOMAIN (POU DOMAIN) OF TRANSCRIPTION FACTOR OCT-1 SUFFICES FOR STIMULATION OF DNA-REPLICATION
    VERRIJZER, CP
    KAL, AJ
    VANDERVLIET, PC
    EMBO JOURNAL, 1990, 9 (06): : 1883 - 1888
  • [32] DNA-BINDING SPECIFICITIES OF THE GATA TRANSCRIPTION FACTOR FAMILY
    KO, LJ
    ENGEL, JD
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 4011 - 4022
  • [33] THE ROLE OF DYNAMICS IN TRANSCRIPTION FACTOR DNA-BINDING SPECIFICITY
    Scheu, Karlton
    De, Soymya
    McIntosh, Lawrence
    PROTEIN SCIENCE, 2019, 28 : 123 - 124
  • [34] Dimerization and DNA-binding properties of the transcription factor ΔFosB
    Jorissen, Helena J. M. M.
    Ulery, Paula G.
    Henry, Lisa
    Gourneni, Sreekrishna
    Nestler, Eric J.
    Rudenko, Gabby
    BIOCHEMISTRY, 2007, 46 (28) : 8360 - 8372
  • [35] An Allosteric Transcription Factor DNA-Binding ElectrochemicalBiosensor for Progesterone
    Sankar, Karthika
    Baer, R.
    Grazon, Chloe
    Sabatelle, Robert C.
    Lecommandoux, Sebastien
    Klapperich, Catherine M.
    Galagan, James E.
    Grinstaff, Mark W.
    ACS SENSORS, 2022, 7 (04) : 1132 - 1137
  • [36] Transcription activation by the DNA-binding domain of the AraC family protein RhaS in the absence of its effector-binding domain
    Wickstrum, Jason R.
    Skredenske, Jeff M.
    Kolin, Ana
    Jin, Ding J.
    Fang, Jianwen
    Egan, Susan M.
    JOURNAL OF BACTERIOLOGY, 2007, 189 (14) : 4984 - 4993
  • [37] The role of activating transcription factor-2 in skeletal growth control
    Luvalle, P
    Ma, Q
    Beier, F
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A : 133 - 136
  • [38] Structure of a Novel DNA-binding Domain of Helicase-like Transcription Factor (HLTF) and Its Functional Implication in DNA Damage Tolerance
    Hishiki, Asami
    Hara, Kodai
    Ikegaya, Yuzu
    Yokoyama, Hideshi
    Shimizu, Toshiyuki
    Sato, Mamoru
    Hashimoto, Hiroshi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (21) : 13215 - 13223
  • [39] An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression
    Y R Rubinstein
    P H Driggers
    V V Ogryzko
    A M Thornton
    K Ozato
    C H Pontzer
    Oncogene, 2000, 19 : 1411 - 1418
  • [40] An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression
    Rubinstein, YR
    Driggers, PH
    Ogryzko, VV
    Thornton, AM
    Ozato, K
    Pontzer, CH
    ONCOGENE, 2000, 19 (11) : 1411 - 1418